Please enable Javascript to use all features and improve your user experience.
DPC 2024
Programme
Search
EN
Back
Session
Session II
Basic science II
incl. welcome
Appointment
Date:
Th, 15/02
Time:
17:00
–
18:30
Location / Stream:
Plenary
Chair
PD Dr. Kim Honselmann
Lübeck / DE
Dr. Shiv K. Singh
Göttingen / DE
Programme
17:00
–
17:10
10 Min.
0 Min.
Invited lecture
Welcome talk
Prof. Jörg C. Kalff (Bonn / DE)
17:10
–
17:20
8 Min.
2 Min.
Oral presentation
O10
Crosstalk of glutamine metabolism and NFATc1 – unfolding vulnerabilities for enhanced therapeutic efficacy in PDAC
Laura Melissa Huhnold (Göttingen / DE)
Pancreatic cancer
17:20
–
17:30
8 Min.
2 Min.
Oral presentation
O11
Coculture of pancreatic stellate and pancreatic adenocarcinoma cells: metabolic characterization
in vitro
and
in vivo
Alina Doctor (Dresden / DE)
Pancreatic cancer
17:30
–
17:40
8 Min.
2 Min.
Oral presentation
O13
Integrin-mediated tumor-stroma interfacial signaling promotes basal-like and immune exclusion phenotype in pancreatic ductal adenocarcinoma
Prof. Yifeng Sun (Heidelberg / DE)
Pancreatic cancer
17:40
–
17:50
8 Min.
2 Min.
Oral presentation
O14
IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts
Dr. Magdalena Huber (Marburg / DE)
Tumour microenvironment, epigenetics and stem cells
17:50
–
18:00
8 Min.
2 Min.
Oral presentation
O15
The roles of GalNT2 and St3Gal6 genes on neural invasion
Alper Dogruöz (München / DE)
Pancreatic cancer
18:00
–
18:10
8 Min.
2 Min.
Oral presentation
O16
CCN1/CYR61 is an important player in the crosstalk between Panc1 cells and pancreartic stellate cells/CAFs affecting chemoresistance to gemcitabine
Rainer Heuchel (Huddinge / SE)
Pancreatic cancer
18:10
–
18:20
8 Min.
2 Min.
Oral presentation
O17
Tumor-immune-microenvironmental implications of targeted SHP2-inhibition +/- MAPK-inhibition in pancreatic cancer
Mrs Asma Alrawashdeh (Freiburg / DE)
Pancreatic cancer
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy